skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Positive modulator of bone morphogenic protein-2

Abstract

Compounds of the present invention of formula I and formula II are disclosed in the specification and wherein the compounds are modulators of Bone Morphogenic Protein activity. Compounds are synthetic peptides having a non-growth factor heparin binding region, a linker, and sequences that bind specifically to a receptor for Bone Morphogenic Protein. Uses of compounds of the present invention in the treatment of bone lesions, degenerative joint disease and to enhance bone formation are disclosed.

Inventors:
; ; ;
Publication Date:
Research Org.:
Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1361549
Patent Number(s):
9,670,258
Application Number:
15/240,977
Assignee:
Brookhaven Science Associates, LLC LBNL
DOE Contract Number:  
ACO2-98CH1086
Resource Type:
Patent
Resource Relation:
Patent File Date: 2016 Aug 18
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES

Citation Formats

Zamora, Paul O., Pena, Louis A., Lin, Xinhua, and Kazuyuki, Takahashi. Positive modulator of bone morphogenic protein-2. United States: N. p., 2017. Web.
Zamora, Paul O., Pena, Louis A., Lin, Xinhua, & Kazuyuki, Takahashi. Positive modulator of bone morphogenic protein-2. United States.
Zamora, Paul O., Pena, Louis A., Lin, Xinhua, and Kazuyuki, Takahashi. Tue . "Positive modulator of bone morphogenic protein-2". United States. doi:. https://www.osti.gov/servlets/purl/1361549.
@article{osti_1361549,
title = {Positive modulator of bone morphogenic protein-2},
author = {Zamora, Paul O. and Pena, Louis A. and Lin, Xinhua and Kazuyuki, Takahashi},
abstractNote = {Compounds of the present invention of formula I and formula II are disclosed in the specification and wherein the compounds are modulators of Bone Morphogenic Protein activity. Compounds are synthetic peptides having a non-growth factor heparin binding region, a linker, and sequences that bind specifically to a receptor for Bone Morphogenic Protein. Uses of compounds of the present invention in the treatment of bone lesions, degenerative joint disease and to enhance bone formation are disclosed.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {Tue Jun 06 00:00:00 EDT 2017},
month = {Tue Jun 06 00:00:00 EDT 2017}
}

Patent:

Save / Share:

Works referenced in this record:

FGF homologs
patent, November 1999


Interleukin-12 fusion protein
patent, November 1999


Osteogenic devices
patent-application, December 2003


Keratinocyte Growth Factor: A Fibroblast Growth Factor Family Member with Unusual Target Cell Specificity
journal, December 1991


Semirational design of a potent, artificial agonist of fibroblast growth factor receptors
journal, December 1999

  • Ballinger, Marcus D.; Shyamala, Venkatakrishna; Forrest, Louise D.
  • Nature Biotechnology, Vol. 17, Issue 12, p. 1199-1204
  • DOI: 10.1038/70746

Biosynthesis of human fibroblast growth factor-5.
journal, April 1991

  • Bates, B.; Hardin, J.; Zhan, X.
  • Molecular and Cellular Biology, Vol. 11, Issue 4, p. 1840-1845
  • DOI: 10.1128/MCB.11.4.1840

Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis
journal, April 2000

  • Binétruy‐Tournaire, Roselyne; Demangel, Caroline; Malavaud, Bernard
  • The EMBO Journal, Vol. 19, Issue 7, p. 1525-1533
  • DOI: 10.1093/emboj/19.7.1525

Overlapping Expression and Redundant Activation of Mesenchymal Fibroblast Growth Factor (FGF) Receptors by Alternatively Spliced FGF-8 Ligands
journal, February 1997

  • Blunt, Allison G.; Lawshé, Avril; Cunningham, Michael L.
  • Journal of Biological Chemistry, Vol. 272, Issue 6, p. 3733-3738
  • DOI: 10.1074/jbc.272.6.3733

Powers and Pitfalls in Sequence Analysis: The 70% Hurdle
journal, April 2000


Identification of a cyclic peptide inhibitor of platelet-derived growth factor-BB receptor-binding and mitogen-induced DNA synthesis in human fibroblasts
journal, August 1997


Trans-repressor activity of nuclear glycosaminoglycans on Fos and Jun/AP-1 oncoprotein-mediated transcription
journal, January 1992

  • Busch, S. J.; Martin, G. A.; Barnhart, R. L.
  • The Journal of Cell Biology, Vol. 116, Issue 1, p. 31-42
  • DOI: 10.1083/jcb.116.1.31

A Functional Fibroblast Growth Factor-1 Immunoglobulin Fusion Protein
journal, June 1998

  • Dikov, Michael M.; Reich, Martha B.; Dworkin, Lydia
  • Journal of Biological Chemistry, Vol. 273, Issue 25, p. 15811-15817
  • DOI: 10.1074/jbc.273.25.15811

Tandem Ligation of Multipartite Peptides with Cell-Permeable Activity
journal, January 2003

  • Eom, Khee Dong; Miao, Zhenwei; Yang, Jin-Long
  • Journal of the American Chemical Society, Vol. 125, Issue 1, p. 73-82
  • DOI: 10.1021/ja020529r

Multiple peptide synthesis
journal, April 1995

  • Fox, John E.
  • Molecular Biotechnology, Vol. 3, Issue 3, p. 249-258
  • DOI: 10.1007/BF02789335

Bone Morphogenetic Protein Receptor Complexes on the Surface of Live Cells: A New Oligomerization Mode for Serine/Threonine Kinase Receptors
journal, March 2000

  • Gilboa, L.; Nohe, A.; Geissendorfer, T.
  • Molecular Biology of the Cell, Vol. 11, Issue 3, p. 1023-1035
  • DOI: 10.1091/mbc.11.3.1023

Identification and characterization of a novel member of the fibroblast growth factor family
journal, May 1998


Structural and functional characterization of full-length heparin-binding growth associated molecule.
journal, January 1992

  • Hampton, B. S.; Marshak, D. R.; Burgess, W. H.
  • Molecular Biology of the Cell, Vol. 3, Issue 1, p. 85-93
  • DOI: 10.1091/mbc.3.1.85

Stimulatory Effects of Basic Fibroblast Growth Factor and Bone Morphogenetic Protein-2 on Osteogenic Differentiation of Rat Bone Marrow-Derived Mesenchymal Stem Cells
journal, October 1997

  • Hanada, Keigo; Dennis, James E.; Caplan, Arnold I.
  • Journal of Bone and Mineral Research, Vol. 12, Issue 10, p. 1606-1614
  • DOI: 10.1359/jbmr.1997.12.10.1606

Designing Biomaterials to Direct Biological Responses
journal, June 1999


Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand
journal, March 1999

  • Hsu, H.; Lacey, D. L.; Dunstan, C. R.
  • Proceedings of the National Academy of Sciences, Vol. 96, Issue 7, p. 3540-3545
  • DOI: 10.1073/pnas.96.7.3540

FGF-18, a Novel Member of the Fibroblast Growth Factor Family, Stimulates Hepatic and Intestinal Proliferation
journal, October 1998

  • Hu, Mickey C.-T.; Qiu, Wan R.; Wang, You-ping
  • Molecular and Cellular Biology, Vol. 18, Issue 10, p. 6063-6074
  • DOI: 10.1128/MCB.18.10.6063

Amino-terminal sequences of a novel heparin-binding protein from human, bovine, rat, and chick brain: High interspecies homology
journal, April 1990

  • Huber, Daniel; Gautschi-Sova, Peter; Böhlen, Peter
  • Neurochemical Research, Vol. 15, Issue 4, p. 435-439
  • DOI: 10.1007/BF00969930

Specific Activation of the p38 Mitogen-activated Protein Kinase Signaling Pathway and Induction of Neurite Outgrowth in PC12 Cells by Bone Morphogenetic Protein-2
journal, September 1999

  • Iwasaki, Shoji; Iguchi, Makoto; Watanabe, Kazushi
  • Journal of Biological Chemistry, Vol. 274, Issue 37, p. 26503-26510
  • DOI: 10.1074/jbc.274.37.26503

The NH2-terminal region of the active domain of sonic hedgehog is necessary for its signal transduction
journal, March 1999


Cloning of a Novel Type II Serine/Threonine Kinase Receptor through Interaction with the Type I Transforming Growth Factor-β Receptor
journal, March 1995

  • Kawabata, Masahiro; Chytil, Anna; Moses, Harold L.
  • Journal of Biological Chemistry, Vol. 270, Issue 10, p. 5625-5630
  • DOI: 10.1074/jbc.270.10.5625

Fibroblasts expressing Sonic hedgehog induce osteoblast differentiation and ectopic bone formation
journal, March 1997


BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II
journal, July 2000

  • Kirsch, Thomas; Nickel, Joachim; Sebald, Walter
  • The EMBO Journal, Vol. 19, Issue 13, p. 3314-3324
  • DOI: 10.1093/emboj/19.13.3314

Design and Chemical Synthesis of a Homogeneous Polymer-Modified Erythropoiesis Protein
journal, February 2003

  • Kochendoerfer, Gerd G.; Chen, Shiah-Yun; Mao, Feng
  • Science, Vol. 299, Issue 5608, p. 884-887
  • DOI: 10.1126/science.1079085

Multidomain Synthetic Peptide B2A2 Synergistically Enhances BMP-2 In Vitro
journal, November 2004

  • Lin, Xinhua; Zamora, Paul O; Albright, Sarah
  • Journal of Bone and Mineral Research, Vol. 20, Issue 4, p. 693-703
  • DOI: 10.1359/JBMR.041104

Augmentation of osseous phenotypes in vivo with a synthetic peptide
journal, January 2007

  • Lin, Xinhua; Elliot, J.J.; Carnes, D.L.
  • Journal of Orthopaedic Research, Vol. 25, Issue 4, p. 531-539
  • DOI: 10.1002/jor.20303

Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: Differentiation response distinguishes KGF from EGF family
journal, August 1990

  • Marchese, C.; Messina, A.; Faggioni, A.
  • Journal of Cellular Physiology, Vol. 144, Issue 2, p. 326-332
  • DOI: 10.1002/jcp.1041440219

Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury.
journal, May 1993

  • Marikovsky, M.; Breuing, K.; Liu, P. Y.
  • Proceedings of the National Academy of Sciences, Vol. 90, Issue 9, p. 3889-3893
  • DOI: 10.1073/pnas.90.9.3889

The Mode of Bone Morphogenetic Protein (BMP) Receptor Oligomerization Determines Different BMP-2 Signaling Pathways
journal, November 2001

  • Nohe, Anja; Hassel, Sylke; Ehrlich, Marcelo
  • Journal of Biological Chemistry, Vol. 277, Issue 7, p. 5330-5338
  • DOI: 10.1074/jbc.M102750200

Identification of a Human Type II Receptor for Bone Morphogenetic Protein-4 That Forms Differential Heteromeric Complexes with Bone Morphogenetic Protein Type I Receptors
journal, September 1995

  • Nohno, Tsutomu; Ishikawa, Tetsuya; Saito, Taiichi
  • Journal of Biological Chemistry, Vol. 270, Issue 38, p. 22522-22526
  • DOI: 10.1074/jbc.270.38.22522

Peptide Synthesis via Fragment Condensation
book, November 1994


Structure and Expression of the mRNA Encoding a Novel Fibroblast Growth Factor, FGF-18
journal, July 1998

  • Ohbayashi, Norihiko; Hoshikawa, Masamitsu; Kimura, Sachie
  • Journal of Biological Chemistry, Vol. 273, Issue 29, p. 18161-18164
  • DOI: 10.1074/jbc.273.29.18161

Endothelial Apoptosis as the Primary Lesion Initiating Intestinal Radiation Damage in Mice
journal, July 2001

  • Paris, François; Fuks, Zvi; Kang, Anthony
  • Science, Vol. 293, Issue 5528, p. 293-297
  • DOI: 10.1126/science.1060191

Polymeric system for dual growth factor delivery
journal, November 2001

  • Richardson, Thomas P.; Peters, Martin C.; Ennett, Alessandra B.
  • Nature Biotechnology, Vol. 19, Issue 11, p. 1029-1034
  • DOI: 10.1038/nbt1101-1029

αvβ3 Integrin Mediates the Cell-adhesive Capacity and Biological Activity of Basic Fibroblast Growth Factor (FGF-2) in Cultured Endothelial Cells
journal, December 1997

  • Rusnati, M.; Tanghetti, E.; Dell'Era, P.
  • Molecular Biology of the Cell, Vol. 8, Issue 12, p. 2449-2461
  • DOI: 10.1091/mbc.8.12.2449

Prolonged ectopic calcification induced by BMP-2-derived synthetic peptide
journal, January 2004

  • Saito, Atsuhiro; Suzuki, Yoshihisa; Ogata, Shin-Ichi
  • Journal of Biomedical Materials Research Part A, Vol. 70A, Issue 1, p. 115-121
  • DOI: 10.1002/jbm.a.30071

Enhanced osteogenic promotion around dental implants with synthetic binding motif mimicking bone morphogenetic protein (BMP)-2
journal, January 2006

  • Seol, Yang-Jo; Park, Yoon-Jeong; Lee, Sang-Cheol
  • Journal of Biomedical Materials Research Part A, Vol. 77A, Issue 3, p. 599-607
  • DOI: 10.1002/jbm.a.30639

The challenges of genome sequence annotation or “The devil is in the details”
journal, November 1997

  • Smith, Temple F.; Zhang, Xiaolin
  • Nature Biotechnology, Vol. 15, Issue 12, p. 1222-1223
  • DOI: 10.1038/nbt1197-1222

Alginate hydrogel linked with synthetic oligopeptide derived from BMP-2 allows ectopic osteoinduction in vivo
journal, June 2000


A Novel Isoform of Human Fibroblast Growth Factor 8 Is Induced by Androgens and Associated with Progression of Esophageal Carcinoma
journal, January 2001

  • Tanaka, Shinji; Ueo, Hiroaki; Mafune, Ken-ichi
  • Digestive Diseases and Sciences, Vol. 46, Issue 5, p. 1016-1021
  • DOI: 10.1023/A:1010753826788

Design of Peptides with High Affinities for Heparin and Endothelial Cell Proteoglycans
journal, March 2000

  • Verrecchio, Angela; Germann, Markus W.; Schick, Barbara P.
  • Journal of Biological Chemistry, Vol. 275, Issue 11, p. 7701-7707
  • DOI: 10.1074/jbc.275.11.7701

Engineering of an FGF–proteoglycan fusion protein with heparin-independent, mitogenic activity
journal, June 2000

  • Yoneda, Atsuko; Asada, Masahiro; Oda, Yuko
  • Nature Biotechnology, Vol. 18, Issue 6, p. 641-644
  • DOI: 10.1038/76487

Sonic hedgehog is involved in osteoblast differentiation by cooperating with BMP-2
journal, October 2002

  • Yuasa, Takahito; Kataoka, Hiroko; Kinto, Naoki
  • Journal of Cellular Physiology, Vol. 193, Issue 2, p. 225-232
  • DOI: 10.1002/jcp.10166

Local Delivery of Basic Fibroblast Growth Factor (bFGF) Using Adsorbed Silyl-heparin, Benzyl-bis(dimethylsilylmethyl)oxycarbamoyl-heparin
journal, September 2002

  • Zamora, Paul O.; Tsang, Ray; Peña, Louis A.
  • Bioconjugate Chemistry, Vol. 13, Issue 5, p. 920-926
  • DOI: 10.1021/bc0155216

The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors.
journal, August 1988

  • Zhan, X.; Bates, B.; Hu, X. G.
  • Molecular and Cellular Biology, Vol. 8, Issue 8, p. 3487-3495
  • DOI: 10.1128/MCB.8.8.3487